Exit Glenmark Pharma at Rs 950: Vijay Chopra

Vijay Chopra of enochventures.com told CNBC-TV18, "I think that Glenmark Pharma has the potential to go up to Rs 950 odd. My take is that it is better to stay away from IT and pharma as of now because the commentary which is coming from United States is not really clear. If the Trump administration has harsh stand on the pharmaceutical industries which we are getting to hear about that he is going to drastically cut drug prices, so it is going to affect the balance sheets of pharmaceutical companies.""Most of the top companies including Glenmark, Dr Reddy's Laboratories, Sun Pharma, Lupin have major exports in the Unites States, so my take is that Rs 950 is the level which I would watch out for and there probably you can exit and get into some other story," he added.